Tag: Schizophrenia

Sodium Nitroprusside Shows No Efficacy in Schizophrenia Treatment

15
Researchers question biases of preliminary trials that found that sodium nitroprusside, an antihypertensive drug, has positive effects on schizophrenia symptoms.

The Role of Racial Bias in the Overdiagnosis of Schizophrenia

40
Researchers detect disparity between white and African American patients diagnosed with schizophrenia when symptoms of a mood disorder are present.

Researchers Make the Case to Rename Schizophrenia

31
The authors outline reasons for renaming schizophrenia and the way a change can reform practice.

New Study Investigates Cannabidiol (CBD) for Psychosis

21
A new study examines the effects of CBD as an adjunct therapy to antipsychotic medication for patients diagnosed with schizophrenia.

Non-Pharmacological Interventions More Effective For Health in Schizophrenia

24
Review compares the effectiveness of pharmacological and non-pharmacological interventions for improving physical health outcomes in people diagnosed with schizophrenia.

Better Outcomes Off Medication for Those Recovered from First-Episode Schizophrenia

3
A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioning—and reached full recovery more quickly.

Researchers Warn of “Brain Atrophy” in Children Prescribed Antipsychotics

20
Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.

Two-Thirds of Schizophrenia Patients Do Not Remit on Antipsychotics

21
A new analysis of antipsychotic treatment of schizophrenia (published in Schizophrenia Bulletin) has found that two-thirds of patients treated this way do not experience symptom remission.

New Research on Patient-Centered Deprescribing for Antipsychotics

8
Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.

The Spanish Yoghurt Farm That Cultivates Better Mental Health

1
From Reuters, "'At La Fageda, these people don’t have a label – they are totally integrated – and they start improving, reconstructing themselves without...

“Diagnostic Dissent”: Experiences of Individuals Who Disagreed With Their Diagnosis

68
Researchers investigate the first-person experiences of people who disagreed with their psychiatric diagnosis of psychosis.

New Research Suggests Brain Abnormalities in ‘Schizophrenia’ May Result From Antipsychotics

36
Study finds that reduced cortical thickness and brain surface area associated with 'schizophrenia' may result from antipsychotic drug use.

FDA Defends Decision to Approve Digital Aripiprazole

21
Members of the U.S. Food and Drug Administration’s Psychiatry Products division go on the defensive in a new article, responding to concerns about the agency’s approval of digital aripiprazole.

Early Attention to Life Circumstances and Relationships Improves Outcomes for Psychosis

29
Coordinated care with employment support and family therapy leads to superior outcomes for those diagnosed with psychotic disorders.

The Largest Health Disparity We Don’t Talk About

1
From the New York Times: Americans with depression, bipolar disorder or other serious mental illnesses die 15 to 30 years younger than those without mental...

How to Talk to Somebody Who is Hearing Voices

2
In this piece for MetroUK, Lucy Nichol explains how to best support people in "psychosis," emphasizing the need to believe individuals who hear voices and recognize...

ISPS Australia’s Response to Schizophrenia Awareness Week: Drop the Label!

83
It really is time to drop the label of schizophrenia, and ISPS Australia invites us to consider just that, in favour of understanding human experience and removing the impediments to a person making sense of their experience — impediments that exist due to the primarily biomedical perspectives that continue to dominate the mental health systems.

“25 Years of Madness and Modernism”: A Review

0
In this piece for the Centre for Medical Humanities, James Whitehead reflects on the 25th anniversary celebration of the publication of Louis Sass's Madness and Modernism. "A...

The Sound of Madness

0
From Harper's Magazine: People who hear positive, encouraging voices often seen as spiritual guides or messages and people diagnosed with schizophrenia are usually thought of as...

Distinguishing Dissociative Disorders from Psychotic Disorders: Compounding Alienation

36
If a person recognizes the “alien” parts of themselves as being parts of themselves, they are likely to be seen as having PTSD or a dissociative disorder. If they see the “alien” parts of themselves as being literally aliens, or demons, they will likely be diagnosed as psychotic. But these experiences are really on a spectrum.

A Commentary on the Finnish Analysis of Outcomes of First Episode...

33
There are a number of well-recognised problems with this sort of study and we should be very cautious about accepting its conclusions at face value. The main problem is that it is an ‘observational’ study, not a randomised controlled trial, and these analyses can be seriously misleading. 

Childhood Adversity Influences Levels of Distress in Voice Hearers

3
Research finds that hearing negative voices explains how childhood adversity is related to distress.

Study Explores Māori Community’s Multifaceted Understanding of “Psychosis”

7
A new study explores how “psychosis” and “schizophrenia” are viewed within the Māori community in New Zealand.

Existential Therapy Assists Patients Withdrawing From Psychiatric Drugs

5
Confronting existential anxiety through “Basal Exposure Therapy” shows promising results in people withdrawing from psychotropic drugs.

A Tale of Two Studies

26
With increasing evidence that psychiatric drugs do more harm than good over the long term, the field of psychiatry often seems focused on sifting through the mounds of research data it has collected, eager to at last sit up and cry, here’s a shiny speck of gold! Our drugs do work! One recently published study on withdrawal of antipsychotics tells of long-term benefits. A second tells of long-term harm. Which one is convincing?